The Current Development of Flavivirus Vaccines, Diseases Control and Epidemiological Situation
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines against Tropical and other Infectious Diseases".
Deadline for manuscript submissions: closed (31 March 2025) | Viewed by 561
Special Issue Editors
Interests: Japanese encephalitis vaccine; arbovirus infection; virus evolution; seroepidemiological survey; host-virus cophylogeny; zoonotic diseases
Interests: zoonoses; vaccine development; vaccine against dengue virus; vaccine against Japanese encephalitis virus
Special Issue Information
Dear Colleagues,
The Flavivirus genus consists of viruses that can cause serious diseases, such as Dengue, Zika, West Nile, yellow fever, Japanese encephalitis, and tick-borne encephalitis. This Special Issue focuses on sharing the latest developments and vaccine trends in Flavivirus infection. We welcome your original research articles, reviews, and perspectives on novel experimental vaccine candidates, vaccine strategies, immune responses, and concerns or optimizations related to vaccine strategies. We also welcome related topics on the epidemiological situation and trends of Flavivirus infection.
Dr. Satoru Arai
Prof. Dr. Tsutomu Omatsu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- novel vaccine candidates
- vaccine development
- vaccination
- emerging infectious diseases
- vaccine efficacy
- vaccination strategies
- immunization strategies and public health
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
